Ikena Oncology's market cap is currently $58.37M. The company's EPS TTM is $-1.238; its P/E ratio is ―; Ikena Oncology is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 9.16M	$ 15.62M	$ 30.98M	$ 9.19M	$ 13.75M
Gross Profit	$ 8.14M	$ 13.58M	$ -16.12M	$ -35.65M	$ -11.19M
Operating Income	$ -75.42M	$ -70.90M	$ -34.14M	$ -44.52M	$ -18.49M
EBITDA	$ -74.40M	$ -70.15M	$ -33.59M	$ -44.22M	$ -18.25M
Net Income	$ -68.17M	$ -66.63M	$ -34.12M	$ -44.26M	$ -16.82M
Balance Sheet
Cash & Short-Term Investments	$ 175.47M	$ 156.95M	$ 232.22M	$ 162.49M	$ 82.08M
Total Assets	$ 192.09M	$ 172.26M	$ 247.88M	$ 168.40M	$ 85.97M
Total Debt	$ 10.74M	$ 5.69M	$ 6.99M	$ 186.00K	$ 78.87M
Net Debt	$ -109.16M	$ -54.23M	$ -225.23M	$ -162.31M	$ -3.22M
Total Liabilities	$ 22.34M	$ 25.29M	$ 40.00M	$ 269.45M	$ 147.44M
Stockholders' Equity	$ 169.76M	$ 146.97M	$ 207.88M	$ -101.05M	$ -61.46M
Cash Flow
Free Cash Flow	$ -80.16M	$ -75.54M	$ -62.01M	$ -38.59M	$ 47.61M
Operating Cash Flow	$ -79.74M	$ -74.11M	$ -60.25M	$ -37.83M	$ 47.93M
Investing Cash Flow	$ 64.14M	$ -99.28M	$ -1.76M	$ 2.92M	$ -316.00K
Financing Cash Flow	$ 75.98M	$ 1.09M	$ 131.74M	$ 116.18M	$ 16.32M

Currency in USD

Ikena Oncology Earnings and Revenue History

Income Statement >

Ikena Oncology Debt to Assets

Balance Sheet >

Ikena Oncology Cash Flow

Cash Flow >

Ikena Oncology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing